Chemo Pharma Laboratories Ltd - 506365 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
We submit herewith the confirmation certificate received from M/s. Purva Sharegistry (India) Private Limited, Registrar and Share Transfer Agent (RTA) as per regulation 74(5) of the SEBI (Depositories and Participants) Regulations, 2018 for the quarter and half ended September 30, 2019. CHEMO PHARMA LABORATORIES LTD. - 506365 - Board Meeting Intimation for INTIMATION OF BOARD MEETING TO BE HELD ON TUESDAY,22ND OCTOBER,2019
CHEMO PHARMA LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 22/10/2019 ,inter alia, to consider and approve 1.To consider and approve the Un-Audited Financial Results and Statement of Assets and Liability for the Quarter and Half year ended 30th September, 2019. 2.To place and take on record the Limited Review Report on Un-Audited Financial Results for the quarter ended 30th September, 2019. Chemo Pharma Laboratories Ltd - 506365 - Statement Of Investor Complaints For The Quarter Ended September 2019 (Revised)
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ashok SomaniDesignation :- Director CHEMO PHARMA LABORATORIES LTD. - 506365 - Statement Of Investor Complaints For The Quarter Ended September 2019
No.of Investor complaints pending at the beginning of the quarter No.of Investor complaints received during the quarter No.of Investor complaints disposed of during the quarter No.of Investor complaints unresolved at the end of the quarter 0000 Name of the Signatory :- Ashok SomaniDesignation :- Director Chemo Pharma Laboratories Ltd - 506365 - Closure of Trading Window
This is to inform you that as per the Company''s Code of Conduct to regulate, monitor and report trading by insiders (''Code''), the Trading Window for dealing in the securities of the Company has been closed for all the Designated Persons and their relatives with effect from October 1, 2019 till 48 (forty eight) hours after the financial results of the Company for the quarter ended September 30, 2019 become generally available information. Kindly take the above information on your records. Chemo Pharma Laboratories Ltd - 506365 - Shareholder Meeting / Postal Ballot-Scrutinizer''s Report
Pursuant to regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, we submit herewith the details regarding the voting results of the business transacted at the 77th Annual General Meeting (AGM) of the Members of the Company held on Tuesday, August 27, 2019, at the Registered Office of the Company. We are also enclosing the report of the scrutinizer on e-voting and voting through ballot paper at the AGM. A copy of the above is being uploaded in the website of the Company and Central Depository Securities Limited (CDSL). Chemo Pharma Laboratories Ltd - 506365 - Disclosure of Voting results of AGM (Regulation 44(3) of SEBI (LODR) Regulations, 2015)
Chemo Pharma Laboratories Ltd has informed BSE regarding the details of Voting results of AGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly Click here CHEMO PHARMA LABORATORIES LTD. - 506365 - Announcement under Regulation 30 (LODR)-Change in Directorate
DISCLOSURE OF EVENTS / INFORMATION UNDER REGULATION 30 OF SEBI (LISTING OBLIGATIONS AND DISCLOSURE REQUIREMENTS) REGULATIONS, 2015 CHEMO PHARMA LABORATORIES LTD. - 506365 - Shareholder Meeting / Postal Ballot-Outcome of AGM
Pursuant to Regulation 44(3) of SEBI (Listing Obligations and Disclosure Requirements), 2015, we are submitting herewith the proceedings of the 77th Annual General Meeting (AGM) of the Members of the Company held on Tuesday, 27th August, 2019 at the Registered Office of the Company Chemo Pharma Laboratories Ltd - 506365 - Reg. 34 (1) Annual Report
Submission of Annual Report pursuant to Regulation 34 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) (Amendment) Regulations, 2018 for the financial year ended 31st March 2019 including Notice of the 77th Annual General Meeting